Bank of America’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,344
Closed -$3K 7569
2020
Q3
$3K Hold
2,344
﹤0.01% 6684
2020
Q2
$3K Hold
2,344
﹤0.01% 6645
2020
Q1
$2K Hold
2,344
﹤0.01% 6678
2019
Q4
$2K Sell
2,344
-4,200
-64% -$3.27K ﹤0.01% 6928
2019
Q3
$5K Sell
6,544
-8,000
-55% -$36.7K ﹤0.01% 6869
2019
Q2
$117K Hold
14,544
﹤0.01% 5928
2019
Q1
$79K Hold
14,544
﹤0.01% 5996
2018
Q4
$52K Hold
14,544
﹤0.01% 6206
2018
Q3
$128K Buy
14,544
+8,000
+122% +$76.6K ﹤0.01% 5752
2018
Q2
$63K Hold
6,544
﹤0.01% 6021
2018
Q1
$53K Hold
6,544
﹤0.01% 6022
2017
Q4
$46K Hold
6,544
﹤0.01% 6098
2017
Q3
$34K Hold
6,544
﹤0.01% 6103
2017
Q2
$61K Hold
6,544
﹤0.01% 5797
2017
Q1
$125K Buy
+6,544
New +$124K ﹤0.01% 5524

Other funds holding NTRP

Bank of America's NTRP Position: Q4 2020 in Review

Bank of America sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 2,344 shares — an estimated $3K sold.

Bank of America first reported a position in NTRP in Q1 2017 and held it in 15 quarters. The position peaked at $128K in Q3 2018. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • Bank of America reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 2,344 Neurotrope, Inc. Common shares in Q4 2020, an estimated $3K.
  • Bank of America first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 15 quarters.
  • Bank of America's Neurotrope, Inc. Common position peaked at $128K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.